Bio-Path Holdings, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Bio-Path Holdings, Inc. (BPTH) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $11.00 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2026-05-20
- Bio-Path Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2026-03-31 was $11.00K, a 87.50% decline year-over-year.
- Bio-Path Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $25.00K.
- Bio-Path Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-06-30 was -$56.00K.
- Bio-Path Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-03-31 was $88.00K.
- Bio-Path Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $88.00K.
- Bio-Path Holdings, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $85.00K.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-03-31 | $11.00K 10-Q · filed 2026-05-20 | |||
| 2025-09-30 | $25.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-01-13 | -$31.00K derived: sum of 2 quarters · filed 2026-01-13 | $57.00K 10-Q · filed 2026-01-13 | |
| 2025-06-30 | -$56.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $32.00K 10-Q · filed 2025-08-14 | ||
| 2025-03-31 | $88.00K 10-Q · filed 2026-05-20 | |||
| 2024-12-31 | $88.00K 10-K · filed 2025-03-27 | |||
| 2023-03-31 | $85.00K 10-Q · filed 2024-05-14 | $85.00K derived: sum of 2 quarters · filed 2024-05-14 | $85.00K derived: sum of 3 quarters · filed 2024-05-14 | $85.00K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-07 | $0.00 derived: sum of 2 quarters · filed 2024-03-07 | $0.00 derived: sum of 3 quarters · filed 2024-03-07 | $85.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $0.00 derived: sum of 2 quarters · filed 2023-11-14 | $85.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $85.00K 10-Q · filed 2023-08-14 | ||
| 2022-03-31 | $85.00K 10-Q · filed 2023-05-11 | |||
| 2019-09-30 | $407.00K 10-Q · filed 2019-11-14 |